MedPath

Comparative Clinical Evaluation of Daily Disposable Lenses in Symptomatic Lens Wearers

Not Applicable
Completed
Conditions
Myopia
Registration Number
NCT00953407
Lead Sponsor
CIBA VISION
Brief Summary

The purpose of this trial is to evaluate the extent to which symptoms improve in symptomatic contact lens wearers when fit with one of 5 different daily disposable contact lenses.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
128
Inclusion Criteria
  • Currently wear spherical, soft contact lenses replaced at intervals of 2 weeks or monthly.
  • Habitually wear lenses for at least 8 hours per day, 4 days per week, for at least the past 6 months.
  • Report 2 or more qualifying symptoms with current contact lenses with a frequency of "frequently" or "all the time"
  • Able to achieve VA of at least 20/40 in each eye with habitual correction and with study lenses at dispense.
  • Other protocol inclusion/exclusion criteria may apply.
Exclusion Criteria
  • Eye injury or surgery within twelve weeks immediately prior to enrollment.
  • Currently enrolled in any clinical trial.
  • Any use of medications for which contact lens wear could be contraindicated as determined by the investigator.
  • History of corneal refractive surgery.
  • Cylinder correction greater than 1.00 D.
  • Current monovision contact lens wearers.
  • Other protocol inclusion/exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Lens Awareness4 weeks of wear

Lens awareness, as interpreted by the subject, was reported by the subject as a single, retrospective evaluation of 4 week's wear time. Frequency of lens awareness was measured on a 4-point scale, with 1 being never and 4 being all the time. Four-week ratings were compared to baseline ratings, and a negative difference (4-week minus baseline) represented an improvement.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.